Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function

Southern Medical Journal

Volumn 89, Issue 8, 1996, Pages 779-785

  Kumar, Anand ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CRITICAL ILLNESS; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OXYGEN SUPPLY; SYSTOLIC BLOOD PRESSURE;

EID: 0029799984     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199608000-00005     Document Type: Article

References (31)

1. Goldman S, Probst P, Selzer A, et al: Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol 1975; 35:651-655
2. Falk RH, Knowlton AA, Bernard SA, et al: Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. Ann Intern Med 1989; 106:503-506
3. Charlier R: Cardiac actions, in the dog, of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoreceptors. Br J Pharmarol 1970; 39:668-674
4. Singh BN: Amiodarone: historical development and pharmacologic profile. Am Heart J 1983; 106:788-797
5. Nattel S, Talajie M, Quantz M, et al: Frequency-dependent effects of amiodarone on atrio-ventricular nodal function and slow-channel action potentials: evidence for calcium channel blocking activity. Circulation 1987; 76:442-449
6. Ochi RP, Goldenberg IF, Almquist A, et al: Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Am J Cardiol 1989; 64:599-603
7. Morady F, Scheinman MM, Shen E, et al: Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. Am J Cardiol 1983; 51:156-159
8. Klein RC, Machell C, Rushforth N, et al: Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. Am Heart J 1988; 115:96-101
9. Helmy I, Herre JM, Gee G, et al: Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias. J Am Coll Cardiol 1988; 12:1015-1022
10. Nalos PC, Ismail Y, Pappas JM, et al: Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Am Heart J 1991; 122:1629-1632
11. Mooss AN, Mohiuddin SM, Hee TT, et al: Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990; 65:609-614
12. Leak D: Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Am Heart J 1986; 111:456-462
13. Alves LE, Rose EP, Cahill TB: Intravenous amiodarone in the treatment of refractory arrhythmias. Crit Care Med 1985; 13:750-752
14. Holt P, Crick JCP, Davies DW, et al: Intravenous amiodarone in the acute termination of supraventricular arrhythmias. Int J Cardiol 1985; 8:67-76
15. Strasberg B, Arditti A, Sclarovsky S, et al: Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Int J Cardiol 1985; 7:47-55
16. Faniel R, Schoenfeld PH: Efficacy of IV amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J 1983; 4:180-185
17. Sannia L, Frau G, Dore L, et al: Pharmacologic cardioversion with intravenous amiodarone. Boll Soc Ital Cardiol 1980; 26:553-558
18. Vietti-Ramus G, Veglio F, Marchisio U, et al: Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. Int J Cardiol 1992; 35:77-85
19. Noc M, Stajer D, Horvat M: Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 1990; 65:679-680
20. Horner SM: A comparison of cardioversion of atrial fibrillation using oral amiodarone, intravenous amiodarone and DC cardioversion. Acta Cardiol 1992; 157:473-480
21. Bigger JT Jr, Heissenbuttel RH: The use of procainamide and lidocaine in the treatment of cardiac arrhythmias. Prog Cardiovasc Dis 1969; 11:515-534
22. Harrison DC, Sprouse JH, Morrow AG: The antiarrhythmic properties of lidocaine and procainamide. Circulation 1963; 28:486-491
23. McClendon RL, Hansen WR, Kinsman JM: Hemodynamic changes following procaine amide administered intravenously. Am J Med Sci 1951; 222:375-381
24. Kosinski EJ, Albin JB, Young E, et al: Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 1984; 4:565-570
25. Cote P, Bourassa MG, Delaye J, et al: Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation 1979; 69:1165-1172
26. Pfisterer M, Burkart F, Muller-Brand J, et al: Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. J Am Coll Cardiol 1985; 5:1205-1211
27. Schwartz A, Shen E, Morady F, et al: Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am Heart J 1983; 106:848-856
28. Installe E, Schoevaerdts JC, Gadisseux PH, et al: Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. J Thorac Cardiovasc Surg 1981; 81:302-308
29. Gomes JAC, Kang PS, Hariman RJ, et al: Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. Am Heart J 1984; 107:214-221
30. Remme WJ, Kruyssen HACM, Look MP, et al: Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Am Heart J 1991; 122:96-103
31. Morelli S, Guido V, De Marzio P, et al: Early hepatitis during intravenous amiodarone administration. Cardiology 1991; 78:291-294